Hun-Jung Kim

Inha University Hospital

Papers

1

Total Citations

22

H-Index

1

About

Hun-Jung Kim is a leading radiation oncologist whose research centers on stereotactic body radiotherapy (SBRT) for prostate cancer, with a particular focus on optimizing treatment outcomes and understanding post-treatment PSA kinetics. His most significant contribution is the landmark multicenter retrospective study (Korean Radiation Oncology Group study 15-01), which evaluated long-term results and PSA dynamics after robotic SBRT for localized prostate cancer across three academic hospitals in Korea. This work, cited 22 times, provided crucial insights into the efficacy and biochemical response patterns of SBRT, helping to establish treatment benchmarks and refine patient selection criteria. Kim’s research has directly influenced clinical practice by demonstrating the safety and effectiveness of high-precision, hypofractionated radiation delivery. His findings on PSA kinetics offer valuable guidance for clinicians monitoring patients after SBRT, aiding in the early detection of potential recurrences. Through this collaborative, multi-institutional effort, Kim has advanced the evidence base for non-invasive prostate cancer treatment, contributing to the growing adoption of SBRT as a standard option for localized disease.

Research Focus

Key Achievements

1
H-Index
1
Papers
22
Total Citations
22
Avg Citations/Paper
🏆 Most Cited Paper
Long-term results and PSA kinetics after robotic SBRT for prostate cancer: multicenter retrospective study in Korea (Korean radiation oncology group study 15–01)
22 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Inha University Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago